Coya Therapeutics (COYA) Stock Chart & Stock Price History $5.45 -0.65 (-10.66%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$5.81 +0.36 (+6.68%) As of 04/4/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Coya Therapeutics Stock Price Performance 5 Day Performance-15.77%1 Month Performance-16.41%3 Month Performance-10.80%6 Month Performance-24.93%Year-To-Date Performance-4.89%1 Year Performance-42.99% Receive COYA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address COYA Stock Chart for Saturday, April, 5, 2025 COYA Chart by TradingViewRemove Ads Coya Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/04/2025$6.10$5.45-10.66%$6.11$5.45126,493 shs$91.15 million04/03/2025$6.54$6.10-6.73%$6.48$6.0149,541 shs$102.02 million04/02/2025$6.31$6.54+3.65%$6.57$6.2225,637 shs$109.38 million04/01/2025$6.47$6.31-2.47%$6.67$6.1272,610 shs$105.54 million03/31/2025$6.56$6.47-1.37%$6.72$6.4037,845 shs$108.21 million03/28/2025$6.89$6.56-4.79%$7.06$6.5233,739 shs$109.72 million03/27/2025$6.51$6.89+5.84%$6.94$6.5059,996 shs$115.24 million03/26/2025$6.55$6.51-0.61%$6.71$6.4078,333 shs$108.88 million03/25/2025$6.65$6.55-1.50%$6.75$6.3635,664 shs$109.55 million03/24/2025$6.68$6.65-0.45%$6.79$6.5137,261 shs$111.22 million Get the Latest News and Ratings for COYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/21/2025$6.47$6.68+3.25%$6.68$6.2049,741 shs$111.60 million03/20/2025$6.45$6.47+0.31%$6.58$6.3070,693 shs$108.09 million03/19/2025$6.45$6.45$6.58$6.1874,684 shs$107.76 million03/18/2025$6.85$6.45-5.84%$7.03$6.45118,503 shs$107.76 million03/17/2025$6.49$6.85+5.55%$7.05$6.3848,515 shs$114.44 million03/14/2025$6.48$6.49+0.15%$6.75$6.22113,745 shs$108.43 million03/13/2025$6.63$6.48-2.26%$6.85$6.3425,182 shs$108.26 million03/12/2025$6.70$6.63-1.04%$6.96$6.4753,463 shs$110.77 million03/11/2025$6.54$6.70+2.45%$6.86$6.2139,383 shs$111.94 million03/10/2025$6.88$6.54-4.94%$7.10$6.4179,486 shs$109.26 million03/07/2025$6.29$6.88+9.38%$7.38$6.16629,612 shs$114.94 million03/06/2025$6.52$6.29-3.53%$6.72$6.2753,092 shs$105.09 million03/05/2025$6.79$6.52-3.98%$6.87$6.4739,818 shs$108.93 million03/04/2025$7.40$6.79-8.24%$7.86$6.77173,013 shs$113.44 million Related Companies Phathom Pharmaceuticals Stock Chart Tourmaline Bio Stock Chart Keros Therapeutics Stock Chart Autolus Therapeutics Stock Chart Verve Therapeutics Stock Chart Zevra Therapeutics Stock Chart CorMedix Stock Chart ORIC Pharmaceuticals Stock Chart ABIVAX Société Anonyme Stock Chart SIGA Technologies Stock Chart Receive COYA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COYA) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.